Gene Symbol | Gene ID | Gene Info |
---|---|---|
IKZF1
|
ENSG00000185811.12 | IKAROS family zinc finger 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_50304553_50304704 | IKZF1 | 39696 | 0.195286 | 0.95 | 1.1e-04 | Click! |
chr7_50266300_50266494 | IKZF1 | 77927 | 0.096542 | 0.92 | 4.8e-04 | Click! |
chr7_50304806_50304957 | IKZF1 | 39443 | 0.196110 | 0.89 | 1.5e-03 | Click! |
chr7_50305907_50306413 | IKZF1 | 38164 | 0.200294 | 0.88 | 1.7e-03 | Click! |
chr7_50308362_50308737 | IKZF1 | 35775 | 0.208171 | 0.88 | 1.9e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr21_45773824_45774183 | 1.41 |
TRPM2 |
transient receptor potential cation channel, subfamily M, member 2 |
432 |
0.69 |
chr1_203733210_203733579 | 1.29 |
LAX1 |
lymphocyte transmembrane adaptor 1 |
910 |
0.54 |
chr14_98689187_98689819 | 1.26 |
ENSG00000222066 |
. |
108584 |
0.07 |
chr19_42376134_42376473 | 1.22 |
CD79A |
CD79a molecule, immunoglobulin-associated alpha |
4887 |
0.12 |
chr17_8804196_8804468 | 1.22 |
PIK3R5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
10492 |
0.22 |
chr17_79318286_79318703 | 1.18 |
TMEM105 |
transmembrane protein 105 |
14020 |
0.13 |
chr3_193973611_193973933 | 1.10 |
CPN2 |
carboxypeptidase N, polypeptide 2 |
98275 |
0.06 |
chr19_35703159_35703542 | 1.08 |
FAM187B |
family with sequence similarity 187, member B |
16282 |
0.09 |
chr6_33871752_33872302 | 1.07 |
ENSG00000221697 |
. |
95801 |
0.06 |
chr22_24039273_24039542 | 1.05 |
RGL4 |
ral guanine nucleotide dissociation stimulator-like 4 |
736 |
0.54 |
chr11_117886387_117886681 | 1.04 |
IL10RA |
interleukin 10 receptor, alpha |
29425 |
0.14 |
chr7_149565914_149566574 | 1.03 |
ATP6V0E2 |
ATPase, H+ transporting V0 subunit e2 |
3813 |
0.19 |
chr6_56818665_56819033 | 1.03 |
DST |
dystonin |
536 |
0.61 |
chr8_134071429_134072001 | 1.02 |
SLA |
Src-like-adaptor |
888 |
0.68 |
chr6_35278431_35279308 | 1.02 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
1354 |
0.42 |
chr22_39477037_39477448 | 1.01 |
APOBEC3G |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G |
4232 |
0.15 |
chr15_64184559_64184758 | 0.99 |
ENSG00000199156 |
. |
21440 |
0.19 |
chr14_98190257_98190652 | 0.98 |
RP11-204N11.1 |
Uncharacterized protein |
38714 |
0.23 |
chr7_142502793_142502964 | 0.98 |
PRSS3P2 |
protease, serine, 3 pseudogene 2 |
21747 |
0.16 |
chr10_99259428_99259670 | 0.97 |
UBTD1 |
ubiquitin domain containing 1 |
924 |
0.33 |
chr11_4113400_4113717 | 0.97 |
RRM1 |
ribonucleotide reductase M1 |
2481 |
0.29 |
chr11_121324841_121325286 | 0.95 |
RP11-730K11.1 |
|
1341 |
0.45 |
chr3_13052264_13052559 | 0.95 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
23875 |
0.24 |
chr17_46517915_46518153 | 0.95 |
SKAP1 |
src kinase associated phosphoprotein 1 |
10453 |
0.14 |
chr12_6571504_6572054 | 0.94 |
VAMP1 |
vesicle-associated membrane protein 1 (synaptobrevin 1) |
8032 |
0.09 |
chr12_121530141_121530589 | 0.94 |
ENSG00000201945 |
. |
14481 |
0.16 |
chr17_37836684_37836934 | 0.93 |
ERBB2 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 |
7358 |
0.1 |
chr19_55019778_55020166 | 0.91 |
LAIR2 |
leukocyte-associated immunoglobulin-like receptor 2 |
5849 |
0.11 |
chr9_85834406_85834629 | 0.90 |
RP11-439K3.1 |
|
271 |
0.91 |
chr11_117864673_117864984 | 0.90 |
IL10RA |
interleukin 10 receptor, alpha |
7719 |
0.19 |
chr11_74984720_74985495 | 0.90 |
ARRB1 |
arrestin, beta 1 |
4636 |
0.16 |
chr2_98334295_98334593 | 0.90 |
ZAP70 |
zeta-chain (TCR) associated protein kinase 70kDa |
4421 |
0.2 |
chr1_202132763_202133787 | 0.90 |
PTPN7 |
protein tyrosine phosphatase, non-receptor type 7 |
2559 |
0.21 |
chr19_54872936_54873267 | 0.89 |
LAIR1 |
leukocyte-associated immunoglobulin-like receptor 1 |
545 |
0.63 |
chr2_233942870_233943259 | 0.89 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
17875 |
0.18 |
chr7_149562841_149563242 | 0.88 |
RP4-751H13.7 |
|
3460 |
0.2 |
chr20_418602_419173 | 0.88 |
ENSG00000206797 |
. |
12420 |
0.15 |
chr9_139928311_139928633 | 0.88 |
FUT7 |
fucosyltransferase 7 (alpha (1,3) fucosyltransferase) |
1010 |
0.23 |
chr9_73021961_73022182 | 0.88 |
KLF9 |
Kruppel-like factor 9 |
7469 |
0.28 |
chr9_140355542_140355729 | 0.87 |
NSMF |
NMDA receptor synaptonuclear signaling and neuronal migration factor |
1849 |
0.23 |
chr17_4404014_4404514 | 0.85 |
AC118754.4 |
|
1295 |
0.31 |
chr2_233948147_233948470 | 0.85 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
23119 |
0.17 |
chr1_117360221_117360504 | 0.85 |
CD2 |
CD2 molecule |
63273 |
0.1 |
chr17_76748975_76749305 | 0.84 |
CYTH1 |
cytohesin 1 |
16168 |
0.18 |
chr9_34983449_34984034 | 0.84 |
DNAJB5 |
DnaJ (Hsp40) homolog, subfamily B, member 5 |
5897 |
0.15 |
chr1_203651348_203651722 | 0.84 |
ATP2B4 |
ATPase, Ca++ transporting, plasma membrane 4 |
402 |
0.87 |
chr5_172190769_172190940 | 0.84 |
RP11-779O18.3 |
|
871 |
0.5 |
chr10_74050593_74051050 | 0.83 |
RP11-442H21.2 |
|
15083 |
0.15 |
chr5_98105054_98105343 | 0.83 |
RGMB |
repulsive guidance molecule family member b |
199 |
0.95 |
chr8_27220300_27220714 | 0.83 |
PTK2B |
protein tyrosine kinase 2 beta |
17661 |
0.21 |
chr17_19208968_19209208 | 0.82 |
EPN2-AS1 |
EPN2 antisense RNA 1 |
486 |
0.7 |
chr2_1521809_1522080 | 0.82 |
TPO |
thyroid peroxidase |
14395 |
0.28 |
chr7_142421237_142421461 | 0.82 |
PRSS1 |
protease, serine, 1 (trypsin 1) |
35970 |
0.15 |
chr2_43380824_43381054 | 0.82 |
ENSG00000207087 |
. |
62307 |
0.12 |
chr14_71120441_71121072 | 0.82 |
TTC9 |
tetratricopeptide repeat domain 9 |
12252 |
0.21 |
chr14_22392361_22392865 | 0.82 |
ENSG00000222776 |
. |
143828 |
0.04 |
chr4_90207457_90208038 | 0.82 |
GPRIN3 |
GPRIN family member 3 |
21414 |
0.27 |
chr4_82390413_82390600 | 0.81 |
RASGEF1B |
RasGEF domain family, member 1B |
1884 |
0.5 |
chr14_106642239_106642468 | 0.81 |
IGHV1-18 |
immunoglobulin heavy variable 1-18 |
297 |
0.67 |
chr5_1109028_1109296 | 0.81 |
SLC12A7 |
solute carrier family 12 (potassium/chloride transporter), member 7 |
2988 |
0.24 |
chr14_69287628_69287955 | 0.81 |
ZFP36L1 |
ZFP36 ring finger protein-like 1 |
24601 |
0.17 |
chr17_80259896_80260047 | 0.81 |
CD7 |
CD7 molecule |
15457 |
0.1 |
chr6_33874169_33874610 | 0.81 |
ENSG00000221697 |
. |
93439 |
0.07 |
chr2_97626813_97627234 | 0.80 |
ENSG00000252845 |
. |
4471 |
0.17 |
chr5_133414981_133415351 | 0.80 |
TCF7 |
transcription factor 7 (T-cell specific, HMG-box) |
35236 |
0.17 |
chr11_2399892_2400396 | 0.80 |
CD81 |
CD81 molecule |
242 |
0.8 |
chr12_53024874_53025168 | 0.79 |
KRT73 |
keratin 73 |
12678 |
0.1 |
chr10_6091647_6091971 | 0.79 |
IL2RA |
interleukin 2 receptor, alpha |
12444 |
0.14 |
chr14_104859216_104859500 | 0.79 |
ENSG00000222761 |
. |
8027 |
0.27 |
chr20_4793444_4793878 | 0.79 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
2108 |
0.33 |
chr2_47205897_47206474 | 0.79 |
RP11-15I20.1 |
|
22158 |
0.15 |
chr16_3625514_3626029 | 0.79 |
NLRC3 |
NLR family, CARD domain containing 3 |
1621 |
0.3 |
chr8_20350233_20350530 | 0.79 |
ENSG00000251944 |
. |
122056 |
0.06 |
chr20_31558706_31558907 | 0.78 |
EFCAB8 |
EF-hand calcium binding domain 8 |
11155 |
0.16 |
chr17_73531528_73531742 | 0.78 |
LLGL2 |
lethal giant larvae homolog 2 (Drosophila) |
3061 |
0.15 |
chr1_229171732_229172149 | 0.78 |
RP5-1061H20.5 |
|
191369 |
0.02 |
chr2_37897328_37897589 | 0.78 |
CDC42EP3 |
CDC42 effector protein (Rho GTPase binding) 3 |
1876 |
0.46 |
chr11_46367187_46367549 | 0.78 |
DGKZ |
diacylglycerol kinase, zeta |
381 |
0.82 |
chr1_25950280_25950431 | 0.78 |
MAN1C1 |
mannosidase, alpha, class 1C, member 1 |
6014 |
0.21 |
chr14_91798820_91799198 | 0.77 |
ENSG00000265856 |
. |
1048 |
0.58 |
chr19_47990503_47990712 | 0.77 |
NAPA-AS1 |
NAPA antisense RNA 1 |
3042 |
0.16 |
chr3_33089618_33090123 | 0.77 |
GLB1 |
galactosidase, beta 1 |
48414 |
0.11 |
chr7_99819712_99820188 | 0.77 |
ENSG00000222482 |
. |
2207 |
0.15 |
chr11_14269963_14270251 | 0.77 |
RP11-21L19.1 |
|
25130 |
0.22 |
chr2_213969861_213970084 | 0.77 |
IKZF2 |
IKAROS family zinc finger 2 (Helios) |
43381 |
0.19 |
chr19_54872011_54872636 | 0.76 |
LAIR1 |
leukocyte-associated immunoglobulin-like receptor 1 |
233 |
0.87 |
chr3_4877162_4877585 | 0.76 |
ENSG00000239126 |
. |
43013 |
0.15 |
chr11_67414492_67414700 | 0.76 |
ACY3 |
aspartoacylase (aminocyclase) 3 |
458 |
0.69 |
chr11_60789970_60790185 | 0.76 |
CD6 |
CD6 molecule |
14071 |
0.14 |
chr3_13931501_13932034 | 0.76 |
WNT7A |
wingless-type MMTV integration site family, member 7A |
10149 |
0.22 |
chr15_77307068_77307417 | 0.76 |
PSTPIP1 |
proline-serine-threonine phosphatase interacting protein 1 |
910 |
0.6 |
chr5_1109308_1109459 | 0.76 |
SLC12A7 |
solute carrier family 12 (potassium/chloride transporter), member 7 |
2767 |
0.25 |
chr18_23794523_23794721 | 0.75 |
TAF4B |
TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa |
11278 |
0.23 |
chr3_52252083_52252475 | 0.75 |
ALAS1 |
aminolevulinate, delta-, synthase 1 |
6811 |
0.1 |
chr8_9007531_9007748 | 0.75 |
PPP1R3B |
protein phosphatase 1, regulatory subunit 3B |
567 |
0.67 |
chr3_15397693_15398324 | 0.75 |
SH3BP5 |
SH3-domain binding protein 5 (BTK-associated) |
15133 |
0.13 |
chr12_12160413_12160849 | 0.75 |
BCL2L14 |
BCL2-like 14 (apoptosis facilitator) |
42147 |
0.19 |
chr6_37470020_37470409 | 0.75 |
CCDC167 |
coiled-coil domain containing 167 |
2516 |
0.3 |
chr2_204809141_204809292 | 0.75 |
ICOS |
inducible T-cell co-stimulator |
7713 |
0.29 |
chr19_4088018_4088329 | 0.75 |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
12872 |
0.11 |
chr22_38072661_38072818 | 0.75 |
LGALS1 |
lectin, galactoside-binding, soluble, 1 |
1124 |
0.31 |
chr14_71113404_71113607 | 0.74 |
TTC9 |
tetratricopeptide repeat domain 9 |
5001 |
0.23 |
chr10_87372586_87372791 | 0.74 |
RP11-93H12.2 |
|
7538 |
0.23 |
chr7_99764513_99764874 | 0.74 |
GAL3ST4 |
galactose-3-O-sulfotransferase 4 |
160 |
0.86 |
chr6_52261761_52261957 | 0.74 |
EFHC1 |
EF-hand domain (C-terminal) containing 1 |
23247 |
0.2 |
chr7_50302307_50302807 | 0.74 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
41767 |
0.19 |
chr9_130473290_130473644 | 0.74 |
C9orf117 |
chromosome 9 open reading frame 117 |
702 |
0.5 |
chr11_73686038_73686668 | 0.73 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
1698 |
0.28 |
chr20_31125956_31126117 | 0.73 |
C20orf112 |
chromosome 20 open reading frame 112 |
1836 |
0.32 |
chr20_31169576_31169970 | 0.73 |
RP11-410N8.1 |
|
8 |
0.97 |
chr2_105593697_105593939 | 0.73 |
ENSG00000263685 |
. |
15620 |
0.19 |
chr22_38034183_38034490 | 0.73 |
SH3BP1 |
SH3-domain binding protein 1 |
1146 |
0.32 |
chr11_117693488_117693788 | 0.73 |
FXYD2 |
FXYD domain containing ion transport regulator 2 |
1821 |
0.24 |
chr1_113589732_113590143 | 0.73 |
LRIG2 |
leucine-rich repeats and immunoglobulin-like domains 2 |
25894 |
0.22 |
chr7_150200142_150200645 | 0.73 |
GIMAP7 |
GTPase, IMAP family member 7 |
11525 |
0.18 |
chr1_226860254_226860492 | 0.73 |
ITPKB-IT1 |
ITPKB intronic transcript 1 (non-protein coding) |
2395 |
0.3 |
chr15_44968828_44969014 | 0.73 |
PATL2 |
protein associated with topoisomerase II homolog 2 (yeast) |
101 |
0.96 |
chr1_154310385_154310827 | 0.73 |
ENSG00000238365 |
. |
613 |
0.57 |
chr1_156085465_156085736 | 0.73 |
LMNA |
lamin A/C |
1087 |
0.35 |
chr17_37835970_37836400 | 0.73 |
ERBB2 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 |
7982 |
0.1 |
chr4_8204442_8204682 | 0.72 |
SH3TC1 |
SH3 domain and tetratricopeptide repeats 1 |
3464 |
0.28 |
chr22_42690313_42690589 | 0.72 |
TCF20 |
transcription factor 20 (AR1) |
49171 |
0.13 |
chr1_25197627_25197856 | 0.72 |
RUNX3 |
runt-related transcription factor 3 |
57871 |
0.12 |
chr10_33622577_33623112 | 0.72 |
NRP1 |
neuropilin 1 |
466 |
0.87 |
chr20_24930233_24930895 | 0.72 |
CST7 |
cystatin F (leukocystatin) |
698 |
0.71 |
chr17_8858632_8858856 | 0.72 |
PIK3R5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
10280 |
0.24 |
chr11_128600475_128600823 | 0.72 |
FLI1 |
Fli-1 proto-oncogene, ETS transcription factor |
34036 |
0.15 |
chr1_206729057_206729355 | 0.72 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
1287 |
0.42 |
chr6_41167712_41167899 | 0.72 |
TREML2 |
triggering receptor expressed on myeloid cells-like 2 |
1127 |
0.38 |
chr5_39189552_39189909 | 0.72 |
FYB |
FYN binding protein |
13399 |
0.27 |
chr9_82498334_82498832 | 0.72 |
TLE4 |
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
176902 |
0.04 |
chr14_105759072_105759231 | 0.71 |
BRF1 |
BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit |
7654 |
0.16 |
chr11_114053249_114053976 | 0.71 |
NNMT |
nicotinamide N-methyltransferase |
74941 |
0.09 |
chr11_67177814_67178291 | 0.71 |
CARNS1 |
carnosine synthase 1 |
5097 |
0.07 |
chr8_22023106_22023363 | 0.71 |
BMP1 |
bone morphogenetic protein 1 |
434 |
0.71 |
chr12_58136100_58136469 | 0.71 |
AGAP2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
344 |
0.67 |
chr2_127833518_127833669 | 0.71 |
BIN1 |
bridging integrator 1 |
30984 |
0.2 |
chr19_12775707_12775982 | 0.71 |
MAN2B1 |
mannosidase, alpha, class 2B, member 1 |
1704 |
0.14 |
chr7_8171333_8171763 | 0.71 |
AC006042.6 |
|
17893 |
0.2 |
chr3_32411752_32412018 | 0.71 |
CMTM7 |
CKLF-like MARVEL transmembrane domain containing 7 |
21278 |
0.22 |
chr3_111260178_111260593 | 0.71 |
CD96 |
CD96 molecule |
471 |
0.87 |
chr3_15502764_15502992 | 0.71 |
EAF1-AS1 |
EAF1 antisense RNA 1 |
9769 |
0.12 |
chr11_5246485_5246763 | 0.71 |
ENSG00000221031 |
. |
755 |
0.38 |
chr3_51717463_51717705 | 0.71 |
ENSG00000201595 |
. |
11014 |
0.14 |
chr5_175956521_175957004 | 0.71 |
RNF44 |
ring finger protein 44 |
884 |
0.47 |
chr19_2057508_2057727 | 0.70 |
MKNK2 |
MAP kinase interacting serine/threonine kinase 2 |
6374 |
0.11 |
chr1_9717829_9718205 | 0.70 |
C1orf200 |
chromosome 1 open reading frame 200 |
3373 |
0.21 |
chr10_95241938_95242111 | 0.70 |
MYOF |
myoferlin |
50 |
0.98 |
chr16_50308946_50309418 | 0.70 |
ADCY7 |
adenylate cyclase 7 |
1118 |
0.53 |
chr6_159519924_159520304 | 0.70 |
TAGAP |
T-cell activation RhoGTPase activating protein |
53930 |
0.11 |
chr3_195844958_195845249 | 0.70 |
TFRC |
transferrin receptor |
36043 |
0.13 |
chr8_37430937_37431182 | 0.70 |
RP11-150O12.6 |
|
56520 |
0.12 |
chr10_133975507_133975857 | 0.70 |
RP11-140A10.3 |
|
22821 |
0.18 |
chr14_91865275_91865826 | 0.70 |
CCDC88C |
coiled-coil domain containing 88C |
18140 |
0.22 |
chr17_2498070_2498329 | 0.70 |
PAFAH1B1 |
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) |
1159 |
0.45 |
chr6_10532255_10532561 | 0.70 |
GCNT2 |
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) |
3819 |
0.23 |
chr17_38771842_38772320 | 0.70 |
SMARCE1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 |
16461 |
0.14 |
chr6_41167900_41168146 | 0.70 |
TREML2 |
triggering receptor expressed on myeloid cells-like 2 |
909 |
0.47 |
chr8_144109542_144110058 | 0.70 |
LY6E |
lymphocyte antigen 6 complex, locus E |
9826 |
0.17 |
chr10_134365433_134366156 | 0.69 |
INPP5A |
inositol polyphosphate-5-phosphatase, 40kDa |
14151 |
0.21 |
chr1_25350610_25350934 | 0.69 |
ENSG00000264371 |
. |
778 |
0.7 |
chr3_112192770_112193234 | 0.69 |
BTLA |
B and T lymphocyte associated |
25203 |
0.21 |
chr16_27415395_27415772 | 0.69 |
IL21R |
interleukin 21 receptor |
1160 |
0.52 |
chr7_101109138_101109380 | 0.69 |
COL26A1 |
collagen, type XXVI, alpha 1 |
103137 |
0.06 |
chr4_40194603_40195015 | 0.69 |
RHOH |
ras homolog family member H |
199 |
0.95 |
chr6_33539794_33540088 | 0.69 |
BAK1 |
BCL2-antagonist/killer 1 |
8040 |
0.13 |
chr5_74354344_74354509 | 0.69 |
GCNT4 |
glucosaminyl (N-acetyl) transferase 4, core 2 |
27702 |
0.23 |
chr1_2348493_2348754 | 0.69 |
PEX10 |
peroxisomal biogenesis factor 10 |
3387 |
0.13 |
chr7_150327583_150327838 | 0.69 |
GIMAP6 |
GTPase, IMAP family member 6 |
1724 |
0.37 |
chr3_59997046_59997753 | 0.69 |
NPCDR1 |
nasopharyngeal carcinoma, down-regulated 1 |
39816 |
0.23 |
chr1_169669570_169670044 | 0.69 |
SELL |
selectin L |
11032 |
0.19 |
chr14_91859539_91859984 | 0.69 |
CCDC88C |
coiled-coil domain containing 88C |
23929 |
0.2 |
chr14_53417060_53417453 | 0.69 |
FERMT2 |
fermitin family member 2 |
30 |
0.99 |
chr12_6570561_6570923 | 0.68 |
VAMP1 |
vesicle-associated membrane protein 1 (synaptobrevin 1) |
9069 |
0.09 |
chr2_233924263_233924811 | 0.68 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
140 |
0.96 |
chr19_42051966_42052728 | 0.68 |
CEACAM21 |
carcinoembryonic antigen-related cell adhesion molecule 21 |
3539 |
0.21 |
chr1_155046223_155046558 | 0.68 |
EFNA3 |
ephrin-A3 |
4958 |
0.08 |
chr1_15672005_15672414 | 0.68 |
FHAD1 |
forkhead-associated (FHA) phosphopeptide binding domain 1 |
282 |
0.86 |
chr22_37812410_37812725 | 0.68 |
RP1-63G5.5 |
|
10913 |
0.15 |
chr9_95822386_95822880 | 0.68 |
SUSD3 |
sushi domain containing 3 |
1572 |
0.37 |
chr5_75621996_75622528 | 0.68 |
RP11-466P24.6 |
|
14975 |
0.27 |
chr8_144110458_144110687 | 0.68 |
C8orf31 |
chromosome 8 open reading frame 31 |
10107 |
0.17 |
chr10_43856596_43856747 | 0.68 |
FXYD4 |
FXYD domain containing ion transport regulator 4 |
10419 |
0.17 |
chr16_69165550_69165962 | 0.68 |
CHTF8 |
CTF8, chromosome transmission fidelity factor 8 homolog (S. cerevisiae) |
293 |
0.68 |
chr16_25074374_25074663 | 0.68 |
ARHGAP17 |
Rho GTPase activating protein 17 |
47531 |
0.14 |
chr14_24837393_24837740 | 0.68 |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
19 |
0.94 |
chr9_117134766_117135103 | 0.68 |
AKNA |
AT-hook transcription factor |
4310 |
0.23 |
chr16_3070538_3070989 | 0.68 |
TNFRSF12A |
tumor necrosis factor receptor superfamily, member 12A |
383 |
0.5 |
chr5_118644038_118644270 | 0.67 |
ENSG00000243333 |
. |
1828 |
0.37 |
chr12_49958804_49959153 | 0.67 |
MCRS1 |
microspherule protein 1 |
1244 |
0.33 |
chr1_151806038_151806789 | 0.67 |
RORC |
RAR-related orphan receptor C |
2065 |
0.14 |
chr22_31680905_31681194 | 0.67 |
PIK3IP1 |
phosphoinositide-3-kinase interacting protein 1 |
7332 |
0.11 |
chr9_140346660_140346970 | 0.67 |
NSMF |
NMDA receptor synaptonuclear signaling and neuronal migration factor |
2129 |
0.2 |
chr7_142507332_142507946 | 0.67 |
PRSS3P2 |
protease, serine, 3 pseudogene 2 |
26508 |
0.14 |
chr7_150148399_150148619 | 0.67 |
GIMAP8 |
GTPase, IMAP family member 8 |
791 |
0.61 |
chr19_7415200_7415586 | 0.67 |
CTB-133G6.1 |
|
1545 |
0.34 |
chr12_53592478_53593243 | 0.67 |
ITGB7 |
integrin, beta 7 |
1367 |
0.28 |
chr14_91783008_91783391 | 0.67 |
ENSG00000265856 |
. |
16858 |
0.18 |
chr15_48936439_48936859 | 0.67 |
FBN1 |
fibrillin 1 |
1269 |
0.58 |
chr8_124098691_124098963 | 0.67 |
TBC1D31 |
TBC1 domain family, member 31 |
7074 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.6 | 4.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.5 | 4.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.1 | 8.9 | GO:0007172 | signal complex assembly(GO:0007172) |
1.1 | 5.4 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
1.1 | 4.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.1 | 5.4 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.0 | 7.1 | GO:0046643 | regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.0 | 1.0 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
1.0 | 3.9 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
1.0 | 2.9 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.9 | 8.5 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.8 | 2.5 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.8 | 0.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.8 | 2.5 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.8 | 4.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.8 | 2.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.8 | 1.6 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.8 | 2.3 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.8 | 0.8 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.7 | 1.5 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.7 | 2.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.7 | 2.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.7 | 1.4 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) mature B cell differentiation(GO:0002335) |
0.7 | 2.7 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.7 | 3.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.7 | 1.3 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.7 | 2.0 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.7 | 0.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.6 | 2.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.6 | 1.9 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.6 | 3.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.6 | 1.8 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.6 | 1.8 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.6 | 1.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.6 | 1.2 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.6 | 4.1 | GO:0002063 | chondrocyte development(GO:0002063) |
0.6 | 0.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.6 | 1.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.6 | 1.7 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.6 | 2.3 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.6 | 1.1 | GO:0015809 | arginine transport(GO:0015809) |
0.6 | 1.1 | GO:0033084 | regulation of immature T cell proliferation(GO:0033083) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.6 | 1.7 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.6 | 1.7 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.6 | 1.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.6 | 1.7 | GO:0017085 | response to insecticide(GO:0017085) |
0.6 | 0.6 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.5 | 0.5 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.5 | 1.6 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.5 | 1.6 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.5 | 0.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.5 | 1.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.5 | 2.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.5 | 1.5 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.5 | 1.5 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.5 | 4.5 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.5 | 1.0 | GO:0071674 | positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.5 | 1.0 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.5 | 2.0 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.5 | 1.9 | GO:0048305 | immunoglobulin secretion(GO:0048305) regulation of immunoglobulin secretion(GO:0051023) |
0.5 | 1.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.5 | 0.5 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.5 | 24.1 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.5 | 2.4 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.5 | 1.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.5 | 2.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.5 | 1.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.5 | 1.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.5 | 0.5 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.5 | 1.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 0.5 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.5 | 1.4 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.5 | 2.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.5 | 1.8 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.5 | 6.9 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.5 | 21.4 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.5 | 1.8 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.4 | 3.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.4 | 1.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.4 | 1.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 0.4 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.4 | 0.4 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.4 | 5.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.4 | 1.3 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.4 | 1.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 0.4 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.4 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 1.3 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.4 | 0.4 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.4 | 0.4 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.4 | 1.2 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.4 | 0.4 | GO:0071503 | response to heparin(GO:0071503) |
0.4 | 1.2 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.4 | 0.8 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.4 | 0.8 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.4 | 1.2 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.4 | 0.4 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.4 | 1.2 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.4 | 0.8 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.4 | 1.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.4 | 2.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.4 | 1.2 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 1.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.4 | 0.4 | GO:0010159 | specification of organ position(GO:0010159) |
0.4 | 1.2 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.4 | 2.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.4 | 0.4 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.4 | 12.5 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.4 | 0.4 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.4 | 1.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.4 | 1.6 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.4 | 5.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.4 | 1.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.4 | 1.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 3.8 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.4 | 2.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 6.8 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.4 | 0.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.4 | 2.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.4 | 1.5 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.4 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 0.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 1.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.4 | 1.1 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.4 | 1.5 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 1.1 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.4 | 0.7 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.4 | 0.4 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.4 | 1.8 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.4 | 1.1 | GO:0032621 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.4 | 0.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 1.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 0.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.4 | 1.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.4 | 1.1 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.4 | 2.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.4 | 0.7 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.4 | 0.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.3 | 0.3 | GO:1903312 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.3 | 2.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 1.0 | GO:0070933 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.3 | 0.7 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.3 | 1.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.3 | 0.7 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.3 | 1.0 | GO:0002507 | tolerance induction(GO:0002507) |
0.3 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 1.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 1.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 1.7 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.3 | 0.3 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.3 | 6.0 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.3 | 2.0 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.3 | 5.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.7 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.3 | 1.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.3 | 1.0 | GO:0051532 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.3 | 3.0 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.3 | 1.6 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.3 | 0.7 | GO:0030183 | B cell differentiation(GO:0030183) |
0.3 | 0.3 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.3 | 1.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 1.9 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.3 | 0.3 | GO:0051917 | regulation of fibrinolysis(GO:0051917) |
0.3 | 1.6 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.3 | 0.3 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.3 | 1.0 | GO:0001562 | response to protozoan(GO:0001562) |
0.3 | 0.3 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.3 | 0.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.3 | 1.9 | GO:0050957 | equilibrioception(GO:0050957) |
0.3 | 1.0 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.3 | 1.0 | GO:0030903 | notochord development(GO:0030903) |
0.3 | 4.1 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.3 | 0.3 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
0.3 | 4.7 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.3 | 2.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 0.6 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.3 | 1.3 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 0.9 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.3 | 0.3 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.3 | 0.3 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) auditory receptor cell fate determination(GO:0042668) inner ear receptor cell fate commitment(GO:0060120) |
0.3 | 0.3 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.3 | 1.6 | GO:0021684 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.6 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.3 | 0.3 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
0.3 | 0.6 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.3 | 0.6 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.3 | 0.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.3 | 0.9 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.3 | 0.9 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.3 | 1.5 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.3 | 0.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 0.6 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 1.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.3 | 0.6 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.3 | 1.8 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.3 | 0.9 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.3 | 2.1 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.3 | 2.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.3 | 0.9 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.3 | 0.9 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.3 | 0.3 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.3 | 0.9 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.3 | 1.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.3 | 0.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.3 | 2.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 1.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 1.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.3 | 1.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 0.3 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.3 | 0.9 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.3 | 0.3 | GO:0060992 | response to fungicide(GO:0060992) |
0.3 | 0.9 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.3 | 1.1 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.3 | 1.7 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 1.7 | GO:0048864 | stem cell development(GO:0048864) |
0.3 | 2.0 | GO:0009304 | tRNA transcription(GO:0009304) |
0.3 | 1.1 | GO:0032106 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.3 | 1.4 | GO:0015992 | proton transport(GO:0015992) |
0.3 | 2.3 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 1.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 0.8 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.3 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 0.8 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.3 | 2.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.3 | 0.8 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.3 | 0.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 0.3 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.3 | 1.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.3 | 0.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 1.4 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.3 | 0.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.3 | 0.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.3 | 0.8 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 0.6 | GO:0046328 | regulation of JNK cascade(GO:0046328) |
0.3 | 0.3 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.3 | 1.9 | GO:0002429 | immune response-activating cell surface receptor signaling pathway(GO:0002429) |
0.3 | 0.5 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.3 | 1.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.3 | 1.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 0.8 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.3 | 1.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.3 | 0.3 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.3 | 0.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 1.1 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.3 | 1.4 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 1.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.3 | 0.8 | GO:0044068 | modulation by virus of host process(GO:0019054) modulation by symbiont of host cellular process(GO:0044068) |
0.3 | 6.5 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.3 | 1.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.3 | 3.0 | GO:0045576 | mast cell activation(GO:0045576) |
0.3 | 1.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 0.8 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 0.8 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.3 | 1.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.3 | 0.3 | GO:0046323 | glucose import(GO:0046323) |
0.3 | 1.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.3 | 0.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 0.5 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.3 | 1.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 2.9 | GO:0000303 | response to superoxide(GO:0000303) |
0.3 | 0.5 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.3 | 0.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.3 | 1.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 0.3 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.3 | 0.5 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.3 | 1.3 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.3 | 0.3 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.3 | 1.0 | GO:2000258 | negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.3 | 1.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.3 | 0.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 0.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 0.5 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.3 | 0.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.3 | 0.8 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 2.0 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.3 | 2.3 | GO:0007512 | adult heart development(GO:0007512) |
0.3 | 0.5 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.2 | 2.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 0.5 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 3.7 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.2 | 0.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 1.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 0.2 | GO:0044254 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.2 | 0.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.5 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.2 | 0.2 | GO:1901861 | regulation of striated muscle tissue development(GO:0016202) regulation of muscle tissue development(GO:1901861) |
0.2 | 0.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.2 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.2 | 0.5 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.2 | 0.2 | GO:0032612 | interleukin-1 production(GO:0032612) |
0.2 | 1.2 | GO:0001839 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) |
0.2 | 1.7 | GO:0001504 | neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
0.2 | 0.5 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.2 | 2.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 0.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 0.2 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.2 | 1.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.5 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 1.0 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.2 | 1.2 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.2 | 0.2 | GO:0060579 | ventral spinal cord interneuron differentiation(GO:0021514) ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.2 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 3.6 | GO:0042098 | T cell proliferation(GO:0042098) |
0.2 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.2 | 0.9 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 1.2 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.2 | GO:0006266 | DNA ligation(GO:0006266) DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 0.2 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.2 | 0.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.2 | GO:0002874 | chronic inflammatory response to antigenic stimulus(GO:0002439) regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.2 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.5 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.2 | 1.4 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 1.6 | GO:0030878 | thyroid gland development(GO:0030878) |
0.2 | 1.2 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
0.2 | 0.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 0.2 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.2 | 0.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 0.2 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.2 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.2 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.2 | 0.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 0.5 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.7 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 2.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 0.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.4 | GO:0003171 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.2 | 0.7 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.2 | 0.7 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.2 | 0.2 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.2 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.2 | 0.2 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.2 | 0.4 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 1.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 1.3 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.2 | 0.2 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.2 | 0.2 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.2 | 0.7 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.2 | 0.4 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.2 | 0.4 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.2 | 0.4 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.2 | 0.4 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 | 0.4 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.2 | 0.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 0.6 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.2 | 0.6 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 0.6 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.2 | 2.6 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.2 | 0.6 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.2 | 2.1 | GO:0042596 | fear response(GO:0042596) |
0.2 | 0.9 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.4 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.2 | 0.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 0.4 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 0.8 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 0.2 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 0.2 | GO:0072089 | stem cell proliferation(GO:0072089) |
0.2 | 2.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.2 | 1.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 0.4 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.8 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.2 | 0.2 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.2 | 0.8 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.2 | 1.0 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 3.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 0.4 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
0.2 | 0.2 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.2 | 0.6 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.8 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.2 | 0.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 8.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.2 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.2 | 0.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 1.8 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 2.0 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 2.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 1.6 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.2 | 5.7 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.2 | 2.2 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.2 | 0.6 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 0.6 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.2 | 0.4 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.2 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
0.2 | 1.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.6 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 0.2 | GO:2000351 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.2 | 0.2 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
0.2 | 1.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 2.4 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.2 | 1.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.6 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.4 | GO:0010954 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.2 | 1.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 9.6 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.2 | 0.6 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 0.4 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.2 | 0.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 1.0 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.2 | 1.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 0.6 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.2 | 0.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 3.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 2.7 | GO:0006959 | humoral immune response(GO:0006959) |
0.2 | 1.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 7.3 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.2 | 0.6 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.2 | 0.2 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 1.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.2 | 0.2 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.2 | 0.6 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.2 | 0.4 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.2 | 0.4 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.2 | 0.4 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.2 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.4 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.2 | 0.6 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.2 | 4.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 1.3 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.2 | 0.6 | GO:0035269 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.2 | 0.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 0.4 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 1.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 1.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 1.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 0.2 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.2 | 0.4 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.2 | 0.2 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.2 | 1.5 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.2 | 1.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 1.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.9 | GO:0003407 | neural retina development(GO:0003407) |
0.2 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 0.4 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.5 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.2 | 0.5 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.2 | 0.2 | GO:2000649 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.2 | 0.9 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.2 | 0.2 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.2 | 0.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.5 | GO:0032880 | regulation of protein localization(GO:0032880) |
0.2 | 0.4 | GO:0070828 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.2 | 0.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 2.1 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.2 | 0.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 0.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 1.0 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 3.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.2 | GO:0035094 | response to nicotine(GO:0035094) |
0.2 | 0.3 | GO:0001964 | startle response(GO:0001964) |
0.2 | 0.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.9 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 1.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.2 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.2 | 1.4 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.2 | 1.2 | GO:0072506 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.2 | 1.7 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 1.0 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.2 | 0.5 | GO:0070664 | negative regulation of leukocyte proliferation(GO:0070664) |
0.2 | 0.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 0.7 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 0.5 | GO:0043441 | acetoacetic acid biosynthetic process(GO:0043441) |
0.2 | 0.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 2.2 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 0.3 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.2 | 0.3 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.2 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 1.2 | GO:0001706 | endoderm formation(GO:0001706) |
0.2 | 0.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.3 | GO:1904251 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.2 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.3 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.2 | 0.5 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.2 | 0.7 | GO:0001776 | leukocyte homeostasis(GO:0001776) |
0.2 | 0.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 0.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.2 | 0.3 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.2 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.2 | 1.9 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.2 | 0.6 | GO:0000050 | urea cycle(GO:0000050) |
0.2 | 0.2 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.2 | 1.6 | GO:0048536 | spleen development(GO:0048536) |
0.2 | 0.6 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.2 | 0.6 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.3 | GO:0090399 | replicative senescence(GO:0090399) |
0.2 | 0.5 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 0.3 | GO:0043276 | anoikis(GO:0043276) |
0.2 | 1.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.2 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 2.2 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.2 | 0.5 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.2 | 1.9 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.2 | 0.3 | GO:0090266 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.2 | 1.3 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 0.2 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.2 | 1.3 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.2 | 0.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.3 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.2 | 0.2 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.2 | 0.2 | GO:0045058 | T cell selection(GO:0045058) |
0.2 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.2 | GO:0043092 | L-amino acid import(GO:0043092) L-glutamate import(GO:0051938) |
0.2 | 0.2 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.2 | 0.6 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.2 | 0.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.2 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.2 | 1.8 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.2 | 0.5 | GO:1902808 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.2 | 0.2 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.2 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 6.2 | GO:0007498 | mesoderm development(GO:0007498) |
0.2 | 0.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.2 | 10.4 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 2.4 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.2 | 0.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.2 | 0.3 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.2 | 0.2 | GO:0021766 | hippocampus development(GO:0021766) |
0.2 | 0.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.9 | GO:0010907 | positive regulation of glucose metabolic process(GO:0010907) positive regulation of glycogen biosynthetic process(GO:0045725) |
0.2 | 3.3 | GO:1901799 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.2 | 1.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.3 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.2 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.6 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 1.5 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.1 | 0.4 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 1.5 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.6 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.1 | 1.0 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 0.4 | GO:2000142 | regulation of transcription initiation from RNA polymerase II promoter(GO:0060260) regulation of DNA-templated transcription, initiation(GO:2000142) |
0.1 | 0.4 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 1.0 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.6 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.4 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.6 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.1 | 0.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.6 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 1.7 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.1 | 1.0 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 2.5 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.9 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.4 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.1 | 0.7 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.9 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.6 | GO:0000469 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) cleavage involved in rRNA processing(GO:0000469) endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 1.4 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 1.7 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.1 | GO:0021575 | hindbrain morphogenesis(GO:0021575) |
0.1 | 0.4 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 0.1 | GO:0032200 | telomere organization(GO:0032200) |
0.1 | 3.6 | GO:0016571 | histone methylation(GO:0016571) |
0.1 | 0.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.1 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.8 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 1.9 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 1.1 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 1.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 2.6 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.1 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 5.9 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.8 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.3 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 0.1 | GO:0070897 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 1.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.1 | GO:0021561 | facial nerve development(GO:0021561) |
0.1 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.1 | 1.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.5 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.3 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.5 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 1.5 | GO:0043488 | regulation of RNA stability(GO:0043487) regulation of mRNA stability(GO:0043488) |
0.1 | 0.7 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 4.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.1 | GO:1902749 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.1 | 2.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.7 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.7 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.5 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 0.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.1 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.1 | 0.1 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.1 | 2.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 0.1 | GO:0031281 | positive regulation of cyclase activity(GO:0031281) |
0.1 | 0.1 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 0.1 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.1 | 0.3 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.4 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.5 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 3.5 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.8 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.3 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.1 | 0.8 | GO:0016045 | detection of bacterium(GO:0016045) |
0.1 | 0.3 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.1 | 0.3 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.4 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.1 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.1 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.8 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.1 | 0.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.1 | GO:1903580 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.1 | 1.7 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.1 | 0.4 | GO:1903038 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.1 | 0.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 1.4 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 0.9 | GO:0046794 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.1 | 0.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.3 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.8 | GO:0001947 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.1 | 0.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.1 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.5 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 1.6 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.6 | GO:0006561 | proline metabolic process(GO:0006560) proline biosynthetic process(GO:0006561) |
0.1 | 0.9 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 4.7 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.1 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.7 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.1 | 0.2 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
0.1 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.4 | GO:0010518 | positive regulation of phospholipase activity(GO:0010518) |
0.1 | 0.6 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.1 | 0.8 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.5 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.2 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.6 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.5 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.1 | 0.2 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.4 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 0.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.1 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.1 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 1.1 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.1 | GO:0050704 | positive regulation of interleukin-1 production(GO:0032732) regulation of interleukin-1 secretion(GO:0050704) |
0.1 | 0.1 | GO:0022403 | cell cycle phase(GO:0022403) |
0.1 | 0.5 | GO:0009266 | response to temperature stimulus(GO:0009266) |
0.1 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.3 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.1 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.1 | 0.8 | GO:0051324 | prophase(GO:0051324) |
0.1 | 0.8 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.1 | 0.1 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.5 | GO:0002262 | myeloid cell homeostasis(GO:0002262) |
0.1 | 0.1 | GO:0050670 | regulation of lymphocyte proliferation(GO:0050670) |
0.1 | 1.3 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 3.4 | GO:0007159 | leukocyte cell-cell adhesion(GO:0007159) |
0.1 | 0.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.6 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.8 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) cellular response to topologically incorrect protein(GO:0035967) |
0.1 | 2.2 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 1.4 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 8.3 | GO:0048011 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 1.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 2.7 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.1 | 1.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.7 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.1 | 0.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 1.4 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.2 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.2 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.5 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 7.5 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 0.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.2 | GO:0016198 | axon choice point recognition(GO:0016198) axon midline choice point recognition(GO:0016199) |
0.1 | 0.4 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 9.8 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 1.0 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.1 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.1 | 0.5 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.1 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.1 | 0.3 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.1 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.4 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.1 | 0.2 | GO:0060021 | palate development(GO:0060021) |
0.1 | 0.2 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 3.7 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.1 | GO:0000578 | embryonic axis specification(GO:0000578) zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.5 | GO:0042891 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.1 | 0.3 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.2 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.1 | 0.2 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.1 | 0.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.1 | 1.1 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.2 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 0.5 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.2 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.1 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.3 | GO:0042113 | B cell activation(GO:0042113) |
0.1 | 1.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.7 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.6 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 1.2 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.2 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 1.4 | GO:0044843 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.1 | 1.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.3 | GO:0021675 | nerve development(GO:0021675) |
0.1 | 0.2 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.4 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.1 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 1.5 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.1 | 0.9 | GO:0045665 | negative regulation of neuron differentiation(GO:0045665) |
0.1 | 0.3 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 1.3 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.7 | GO:0001825 | blastocyst formation(GO:0001825) |
0.1 | 1.2 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.3 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.3 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 1.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 1.0 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.1 | 3.0 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.1 | 0.2 | GO:0045047 | protein targeting to ER(GO:0045047) protein localization to endoplasmic reticulum(GO:0070972) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 18.9 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.3 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 0.1 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.9 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.1 | 0.4 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.1 | 0.6 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.8 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.2 | GO:0014889 | muscle atrophy(GO:0014889) |
0.1 | 1.3 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.1 | 0.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 1.3 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) regulation of ERBB signaling pathway(GO:1901184) |
0.1 | 0.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.7 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.1 | 0.2 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.1 | 0.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.1 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.1 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.1 | 6.8 | GO:0050776 | regulation of immune response(GO:0050776) |
0.1 | 0.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 9.8 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 0.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.4 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.1 | 0.1 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.1 | 0.3 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 2.9 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.4 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.1 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.2 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
0.1 | 0.5 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 0.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.2 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.3 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.5 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.1 | 5.9 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.6 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.3 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.1 | 1.8 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 1.4 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.1 | 13.0 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.1 | 0.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0060479 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.1 | 0.7 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.4 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 0.3 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.1 | 4.8 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.1 | 0.4 | GO:0051322 | anaphase(GO:0051322) |
0.1 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 1.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.1 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.1 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0050769 | positive regulation of neurogenesis(GO:0050769) |
0.1 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.2 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.2 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.2 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.1 | 0.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.4 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.4 | GO:0007254 | JNK cascade(GO:0007254) |
0.1 | 0.7 | GO:0031396 | regulation of protein ubiquitination(GO:0031396) |
0.1 | 1.2 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.1 | 0.1 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.1 | 1.1 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.4 | GO:0045453 | bone resorption(GO:0045453) |
0.1 | 0.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.8 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.3 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.9 | GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade(GO:0070304) |
0.1 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 1.0 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 0.1 | GO:0048747 | muscle fiber development(GO:0048747) |
0.1 | 0.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 1.9 | GO:0042384 | cilium assembly(GO:0042384) |
0.1 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 9.8 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.1 | GO:0001708 | cell fate specification(GO:0001708) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.2 | GO:0031623 | receptor internalization(GO:0031623) |
0.1 | 0.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 1.0 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.7 | GO:0043524 | negative regulation of neuron apoptotic process(GO:0043524) negative regulation of neuron death(GO:1901215) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.7 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.1 | 0.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.1 | GO:0033133 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.1 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.1 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.1 | 2.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.5 | GO:0046051 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.1 | 0.1 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.1 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.1 | 0.1 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.6 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.3 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.1 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.1 | 0.9 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.3 | GO:0043523 | regulation of neuron apoptotic process(GO:0043523) regulation of neuron death(GO:1901214) |
0.1 | 0.8 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.1 | 0.5 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.1 | 20.7 | GO:0006412 | translation(GO:0006412) |
0.1 | 1.2 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 0.1 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.1 | 0.3 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.1 | 0.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
0.1 | 0.9 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.1 | 0.6 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0034111 | negative regulation of homotypic cell-cell adhesion(GO:0034111) |
0.1 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.1 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.1 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.1 | 0.6 | GO:0033673 | negative regulation of kinase activity(GO:0033673) |
0.1 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 1.1 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.8 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 1.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.3 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 2.5 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.1 | 0.4 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.1 | 0.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.1 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.1 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.1 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 0.9 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.1 | 4.3 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.1 | GO:0002209 | behavioral defense response(GO:0002209) |
0.1 | 0.3 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.2 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 1.0 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.1 | 0.3 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.3 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.1 | 0.4 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.5 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 1.3 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 0.1 | GO:0071887 | leukocyte apoptotic process(GO:0071887) |
0.1 | 0.2 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 6.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.4 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.1 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.5 | GO:0046660 | female sex differentiation(GO:0046660) |
0.1 | 0.2 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 1.2 | GO:0006887 | exocytosis(GO:0006887) |
0.1 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.2 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.1 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.5 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.1 | 0.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.1 | 2.2 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.4 | GO:0034332 | adherens junction organization(GO:0034332) |
0.1 | 1.7 | GO:0007204 | positive regulation of cytosolic calcium ion concentration(GO:0007204) |
0.1 | 0.4 | GO:0046386 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) deoxyribose phosphate catabolic process(GO:0046386) |
0.1 | 0.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 1.0 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 0.1 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 1.1 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 4.4 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.1 | 6.6 | GO:0034220 | ion transmembrane transport(GO:0034220) |
0.1 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.4 | GO:0042044 | fluid transport(GO:0042044) |
0.1 | 0.3 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 0.2 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 0.2 | GO:0001889 | liver development(GO:0001889) |
0.1 | 0.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.1 | 0.1 | GO:0043049 | otic placode formation(GO:0043049) |
0.1 | 0.3 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.1 | 0.6 | GO:0016180 | snRNA metabolic process(GO:0016073) snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.1 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.1 | GO:0007260 | tyrosine phosphorylation of STAT protein(GO:0007260) |
0.0 | 0.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 1.0 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.0 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.0 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 | 0.5 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.7 | GO:0006913 | nucleocytoplasmic transport(GO:0006913) |
0.0 | 0.0 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.0 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.2 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.0 | 0.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:0050886 | endocrine process(GO:0050886) |
0.0 | 0.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 1.2 | GO:0006260 | DNA replication(GO:0006260) |
0.0 | 0.1 | GO:0010043 | response to zinc ion(GO:0010043) |
0.0 | 0.5 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.0 | 1.2 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.1 | GO:0097696 | JAK-STAT cascade(GO:0007259) STAT cascade(GO:0097696) |
0.0 | 0.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.0 | 0.1 | GO:0044728 | DNA methylation or demethylation(GO:0044728) |
0.0 | 0.1 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 1.4 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.0 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.0 | 0.1 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.2 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.0 | 0.3 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.0 | 0.2 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 1.0 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.0 | 0.0 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.0 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.0 | 0.4 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 3.2 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.2 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.0 | 0.0 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.0 | 0.1 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 0.1 | GO:0046849 | bone remodeling(GO:0046849) |
0.0 | 0.0 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.0 | GO:0060253 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) regulation of glial cell proliferation(GO:0060251) negative regulation of glial cell proliferation(GO:0060253) |
0.0 | 0.0 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.3 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.2 | GO:0035264 | multicellular organism growth(GO:0035264) |
0.0 | 0.0 | GO:0018202 | peptidyl-histidine phosphorylation(GO:0018106) peptidyl-histidine modification(GO:0018202) |
0.0 | 36.4 | GO:1903506 | regulation of transcription, DNA-templated(GO:0006355) regulation of RNA metabolic process(GO:0051252) regulation of nucleic acid-templated transcription(GO:1903506) |
0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.3 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.0 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.0 | 1.9 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.2 | GO:1900543 | negative regulation of purine nucleotide metabolic process(GO:1900543) |
0.0 | 0.2 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.0 | 5.4 | GO:0006955 | immune response(GO:0006955) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.0 | 0.0 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.2 | GO:0009791 | post-embryonic development(GO:0009791) |
0.0 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.2 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.4 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 11.3 | GO:0015031 | protein transport(GO:0015031) |
0.0 | 0.4 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.0 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.1 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.0 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.7 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.0 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:0030819 | positive regulation of cAMP metabolic process(GO:0030816) positive regulation of cAMP biosynthetic process(GO:0030819) |
0.0 | 0.1 | GO:0055013 | cardiac cell development(GO:0055006) cardiac muscle cell development(GO:0055013) |
0.0 | 0.3 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.1 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.1 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 1.0 | GO:0007586 | digestion(GO:0007586) |
0.0 | 2.1 | GO:0030163 | protein catabolic process(GO:0030163) |
0.0 | 0.1 | GO:0032368 | regulation of lipid transport(GO:0032368) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 5.8 | GO:0008219 | cell death(GO:0008219) |
0.0 | 0.1 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.1 | GO:0007369 | gastrulation(GO:0007369) |
0.0 | 0.1 | GO:0009451 | RNA modification(GO:0009451) |
0.0 | 0.0 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.0 | 0.1 | GO:0052646 | glycerol-3-phosphate metabolic process(GO:0006072) alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.2 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.0 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.0 | 0.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.0 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.0 | 0.0 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.0 | GO:0048512 | circadian behavior(GO:0048512) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.1 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.0 | 0.0 | GO:0042435 | serotonin metabolic process(GO:0042428) indole-containing compound biosynthetic process(GO:0042435) primary amino compound metabolic process(GO:1901160) |
0.0 | 5.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.0 | 0.0 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.8 | 1.5 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.8 | 6.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.7 | 5.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.7 | 9.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.6 | 3.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 2.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.6 | 1.8 | GO:0072487 | MSL complex(GO:0072487) |
0.6 | 1.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.6 | 1.7 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.6 | 0.6 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.5 | 5.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 3.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 2.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.5 | 2.6 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.5 | 2.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.5 | 1.5 | GO:0032009 | early phagosome(GO:0032009) |
0.5 | 2.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.5 | 0.5 | GO:0042827 | platelet dense granule(GO:0042827) |
0.5 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 1.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.5 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 1.8 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.4 | 4.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.4 | 1.6 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.4 | 2.4 | GO:0005883 | neurofilament(GO:0005883) |
0.4 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 0.4 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.4 | 1.6 | GO:0043218 | compact myelin(GO:0043218) |
0.4 | 4.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.4 | 1.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 1.2 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.4 | 1.9 | GO:0000791 | euchromatin(GO:0000791) |
0.4 | 2.6 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 2.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 2.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.4 | 3.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.4 | 0.7 | GO:0031904 | endosome lumen(GO:0031904) |
0.4 | 7.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 0.7 | GO:0038201 | TORC1 complex(GO:0031931) TOR complex(GO:0038201) |
0.3 | 1.0 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.3 | 1.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 3.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 0.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.3 | 2.5 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.3 | 6.0 | GO:0005844 | polysome(GO:0005844) |
0.3 | 4.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 1.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 3.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 0.3 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 2.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.3 | 2.0 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.3 | 0.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 4.7 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.3 | 1.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 5.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 2.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 8.6 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 1.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 1.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 0.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 2.8 | GO:0005884 | actin filament(GO:0005884) |
0.3 | 0.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 4.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 28.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 1.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 1.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 1.9 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 0.7 | GO:0001652 | granular component(GO:0001652) |
0.2 | 1.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 5.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 7.0 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.2 | 0.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 1.3 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 1.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 9.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 0.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 0.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 3.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 1.4 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) endoribonuclease complex(GO:1902555) |
0.2 | 4.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 0.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 0.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 1.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 0.6 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.2 | 8.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.6 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 2.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.6 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 0.6 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.2 | 1.6 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.2 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 1.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 1.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.2 | 0.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 1.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 1.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.3 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.2 | 1.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 0.2 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.2 | 2.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 1.2 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.2 | 3.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.8 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 0.5 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.2 | 0.8 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 1.0 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 1.0 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.2 | 4.6 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 1.5 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 1.0 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.1 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.2 | 5.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 7.7 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 0.5 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 0.5 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 0.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 1.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 1.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 3.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 2.1 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 4.5 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 3.6 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.1 | 2.4 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.6 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.1 | 1.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.1 | GO:0000803 | sex chromosome(GO:0000803) X chromosome(GO:0000805) Barr body(GO:0001740) |
0.1 | 7.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 1.4 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 2.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 2.3 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 10.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 2.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.9 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 4.0 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.1 | 0.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 8.0 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 2.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.7 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.4 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 1.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 9.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.2 | GO:0030313 | cell envelope(GO:0030313) |
0.1 | 0.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 4.6 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.4 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.4 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 5.1 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 4.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 3.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.3 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.2 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.8 | GO:0031672 | A band(GO:0031672) |
0.1 | 6.7 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 1.4 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 1.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 2.3 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 7.6 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 3.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.5 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 4.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 2.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 1.4 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 3.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 9.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 1.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.4 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 2.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 14.2 | GO:0005768 | endosome(GO:0005768) |
0.1 | 0.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 1.8 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 1.4 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 6.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 5.6 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 44.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 2.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.5 | GO:0042611 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
0.1 | 17.5 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.1 | 4.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 2.9 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 2.6 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.5 | GO:0030990 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.1 | 0.5 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 1.5 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 3.1 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 292.0 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.2 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 0.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.6 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.2 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.1 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 2.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 0.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 56.6 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 3.7 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 18.0 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.1 | 2.3 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 29.0 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.6 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.1 | 1.6 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 230.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.4 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.5 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.1 | 0.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.0 | GO:0044437 | vacuolar part(GO:0044437) |
0.0 | 1.0 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 1.9 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.2 | GO:0030426 | growth cone(GO:0030426) site of polarized growth(GO:0030427) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 2.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.4 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 4.3 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.2 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 3.2 | GO:0031982 | vesicle(GO:0031982) |
0.0 | 0.0 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 1.0 | GO:0031090 | organelle membrane(GO:0031090) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 1.2 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.5 | 4.6 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.1 | 3.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.0 | 3.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.0 | 2.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.9 | 2.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.9 | 8.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.8 | 5.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.8 | 2.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.7 | 2.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.7 | 3.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.7 | 2.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.7 | 8.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.7 | 3.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.7 | 2.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 2.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 1.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.6 | 3.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.6 | 1.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 1.8 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.6 | 1.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.6 | 4.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.6 | 1.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 4.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 6.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.5 | 9.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.5 | 1.6 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.5 | 6.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.5 | 0.5 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.5 | 18.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.5 | 3.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 1.5 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.5 | 2.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.5 | 3.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 1.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 2.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.5 | 0.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.5 | 2.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 2.0 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.5 | 6.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.5 | 1.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 3.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.5 | 2.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 1.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 1.8 | GO:0015925 | galactosidase activity(GO:0015925) |
0.4 | 1.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 2.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 1.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.4 | 1.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 1.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 1.3 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.4 | 2.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.4 | 2.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 1.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.4 | 1.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 4.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.4 | 3.3 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 2.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 2.4 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.4 | 7.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 19.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 1.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.4 | 2.4 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 2.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 1.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 1.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 2.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.4 | 6.4 | GO:0043621 | protein self-association(GO:0043621) |
0.4 | 1.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 0.4 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.4 | 4.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.4 | 1.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.4 | 6.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 3.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 2.8 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.4 | 1.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 1.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.3 | 1.0 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.3 | 2.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 1.0 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 2.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 1.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 0.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 1.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 1.0 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 1.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 1.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 2.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 5.5 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.3 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 2.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 0.3 | GO:0030172 | troponin C binding(GO:0030172) |
0.3 | 1.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 1.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 1.6 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.3 | 6.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 0.9 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 1.2 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.3 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 0.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 2.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.3 | 0.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 0.9 | GO:0043398 | HLH domain binding(GO:0043398) |
0.3 | 0.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 4.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 3.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.3 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 0.9 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.3 | 4.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.3 | 2.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 0.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 1.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 1.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 0.6 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 0.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 1.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.3 | 0.3 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.3 | 1.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 0.9 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.3 | 3.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 0.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 2.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.3 | 0.8 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.3 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 1.4 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.3 | 1.1 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.3 | 1.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 4.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.3 | 2.7 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.3 | 1.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 0.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 0.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 0.5 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.3 | 1.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 1.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 0.8 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.3 | 1.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.3 | 0.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.3 | 1.8 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 0.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 3.6 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 1.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 1.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 1.0 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 0.5 | GO:0019955 | cytokine binding(GO:0019955) |
0.3 | 1.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 3.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 1.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 1.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 3.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 0.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.3 | 0.8 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 0.7 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 1.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 3.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 1.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.5 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.2 | 1.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.2 | 1.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 1.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 0.7 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.2 | 1.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 1.4 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 1.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 2.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.7 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 1.2 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.2 | 1.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 0.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.2 | 1.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 1.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.7 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 1.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.7 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 2.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 1.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.5 | GO:0043176 | amine binding(GO:0043176) |
0.2 | 0.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 5.8 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 0.7 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 0.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 0.9 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 3.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 0.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 5.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 0.4 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 1.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 1.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 1.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 1.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 0.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 2.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 1.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.6 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.2 | 1.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 5.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.2 | 1.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 1.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 0.8 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.2 | 1.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 0.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 1.2 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.2 | 1.8 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 1.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.2 | 1.2 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 0.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 5.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 0.6 | GO:0016715 | dopamine beta-monooxygenase activity(GO:0004500) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 1.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 4.1 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.2 | 2.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 0.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 3.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 0.6 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.2 | 1.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 6.3 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.2 | 0.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 0.8 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.2 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.2 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 3.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.5 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.2 | 2.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.9 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.5 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.2 | 1.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.9 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.2 | 2.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 0.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 1.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 1.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 0.5 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.5 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 1.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.3 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 0.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 1.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 1.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 19.0 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.2 | 0.8 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.2 | 2.0 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 1.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.5 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 4.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 1.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 2.2 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.2 | 1.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 10.9 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.2 | 0.6 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 30.9 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.2 | 4.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 1.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 1.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 1.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 0.3 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 0.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 2.4 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 1.8 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 1.0 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 3.2 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.3 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.4 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.1 | 0.7 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.6 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 3.0 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 4.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 1.0 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 1.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 1.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 1.4 | GO:0004549 | ribonuclease P activity(GO:0004526) tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 1.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.4 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.7 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 1.8 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 1.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.1 | 0.7 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 2.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 1.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 3.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 1.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 2.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.3 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.1 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.1 | 0.3 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 1.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 7.2 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.8 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.1 | 2.4 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.4 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.6 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 1.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 13.2 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 2.7 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 1.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 13.8 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 4.5 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.2 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.7 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 2.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 2.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.8 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.1 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 1.0 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 3.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.9 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 7.0 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.8 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 1.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 4.5 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.6 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 1.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.1 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.2 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 4.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.3 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.3 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 7.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 1.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 3.4 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 1.7 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 1.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.9 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.4 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.2 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.3 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 0.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.3 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.4 | GO:0016803 | epoxide hydrolase activity(GO:0004301) ether hydrolase activity(GO:0016803) |
0.1 | 0.3 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 1.3 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 1.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.6 | GO:0034979 | histone deacetylase activity(GO:0004407) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent protein deacetylase activity(GO:0034979) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.1 | 0.3 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 1.6 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.1 | 1.5 | GO:0019209 | kinase activator activity(GO:0019209) |
0.1 | 0.5 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 4.8 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.1 | 0.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 48.1 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.6 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 0.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 1.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.2 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.1 | 2.0 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 2.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 1.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.4 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 1.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.8 | GO:0016887 | ATPase activity(GO:0016887) |
0.1 | 2.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 151.8 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.2 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.3 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 1.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.7 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.2 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 23.3 | GO:0032561 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.1 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 3.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 2.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 13.3 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 2.7 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.1 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 5.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.3 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.1 | GO:0015440 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.2 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 14.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.8 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 1.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.1 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 1.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 1.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.3 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 1.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 1.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 0.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.6 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.1 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 1.2 | GO:0004672 | protein kinase activity(GO:0004672) |
0.1 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 1.1 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.1 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.1 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 2.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 2.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 1.0 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 3.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.3 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 1.1 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 1.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 1.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 1.5 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 1.0 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.3 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 2.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.9 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.1 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0004396 | hexokinase activity(GO:0004396) |
0.0 | 0.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 11.2 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 3.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.9 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.0 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.0 | 0.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.6 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.0 | 0.0 | GO:0033265 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
0.0 | 0.3 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.0 | 2.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 7.7 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.0 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 1.9 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.0 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.0 | 5.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 2.2 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 0.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.3 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.0 | 1.8 | GO:0019900 | kinase binding(GO:0019900) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.2 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 30.8 | GO:0004872 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.2 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 2.8 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 3.1 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.5 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 1.0 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.4 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.0 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.0 | 0.1 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 2.3 | GO:0004871 | signal transducer activity(GO:0004871) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.3 | GO:0044389 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.1 | GO:0015370 | solute:sodium symporter activity(GO:0015370) |
0.0 | 3.8 | GO:0035639 | purine ribonucleoside triphosphate binding(GO:0035639) |
0.0 | 0.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.0 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.1 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 13.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.8 | 48.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.8 | 18.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.8 | 8.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.6 | 1.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 14.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.5 | 15.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 19.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.5 | 3.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.5 | 9.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 6.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 6.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 11.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.4 | 0.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 1.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 2.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 0.7 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 3.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 3.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 13.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 5.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 0.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 6.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 5.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 0.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 3.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 2.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 8.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 3.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 1.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 1.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 1.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 8.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 3.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 6.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 3.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 1.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 6.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 1.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 3.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 1.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 4.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 2.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 1.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 1.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 1.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 1.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 0.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 7.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 2.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 0.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 7.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 1.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 2.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 1.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 3.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 1.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 1.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 7.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 1.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 1.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 1.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 2.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 1.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 3.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 2.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 7.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 2.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 4.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 3.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 6.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 2.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 3.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 5.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 2.0 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 3.0 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.2 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 1.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 6.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.1 | PID ATM PATHWAY | ATM pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.0 | 4.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.9 | 23.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.9 | 6.9 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.7 | 17.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.7 | 6.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.6 | 0.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.5 | 5.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 13.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.5 | 11.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.5 | 2.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.5 | 2.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 8.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.5 | 6.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 3.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 5.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 4.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 0.4 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.4 | 3.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 3.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.4 | 5.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 1.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 5.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.4 | 3.3 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.4 | 5.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 3.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 19.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 1.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.3 | 5.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 1.0 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.3 | 0.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 1.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 2.2 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.3 | 0.6 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
0.3 | 10.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 3.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 1.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.3 | 1.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.3 | 0.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 10.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 2.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 1.7 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.3 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.3 | 3.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 3.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 2.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 1.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 3.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 1.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 1.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 1.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 3.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.3 | 1.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 1.0 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.2 | 0.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 5.9 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 9.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 0.5 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.2 | 7.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 4.9 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 2.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 0.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 8.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 1.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 2.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 0.9 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 1.7 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.2 | 5.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 1.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 1.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 0.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 3.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 6.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 4.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.2 | 2.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 1.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 8.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 0.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 2.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 2.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 2.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 1.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 1.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 8.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 2.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 2.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 10.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.2 | 7.6 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 1.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 2.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 1.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 5.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 2.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 1.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 0.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 0.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 0.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 1.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 14.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.2 | 5.3 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.2 | 0.5 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 4.8 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.9 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 2.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 3.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 9.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 2.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 1.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 7.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 2.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 2.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 2.0 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 0.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 1.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 3.6 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 6.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.1 | 0.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 7.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 0.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 1.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 4.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 5.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 2.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 2.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.6 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 2.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 1.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.8 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 2.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 5.9 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 1.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 2.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 4.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 25.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 1.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 2.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 1.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 9.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 3.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.7 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 0.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 6.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.9 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 0.9 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 0.1 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 0.2 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.1 | 0.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 2.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 3.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.2 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 0.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 1.0 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.0 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 2.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.0 | 0.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.3 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.0 | 0.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.0 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.0 | 0.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.2 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 0.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 4.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.0 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.0 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |